Avalo Therapeutics, Inc. (AVTX)
NASDAQ: AVTX · Real-Time Price · USD
16.12
-1.06 (-6.17%)
Sep 11, 2026, 4:00 PM EDT - Market closed
Avalo Therapeutics Employees
Avalo Therapeutics had 33 employees as of December 31, 2025. The number of employees increased by 10 or 43.48% compared to the previous year.
Employees
33
Change (1Y)
10
Growth (1Y)
43.48%
Revenue / Employee
$1,788
Profits / Employee
-$3,040,394
Market Cap
864.52M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 33 | 10 | 43.48% | 33 | 0 |
| Dec 31, 2024 | 23 | 4 | 21.05% | 23 | 0 |
| Dec 31, 2023 | 19 | -1 | -5.00% | 19 | 0 |
| Dec 31, 2022 | 20 | -24 | -54.55% | 20 | 0 |
| Dec 31, 2021 | 44 | 13 | 41.94% | 42 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Ardelyx | 489 |
| Wave Life Sciences | 317 |
| Geron | 258 |
| Rigel Pharmaceuticals | 174 |
| Olema Pharmaceuticals | 150 |
| Theravance Biopharma | 90 |
| Lexicon Pharmaceuticals | 81 |
| Crescent Biopharma | 69 |
AVTX News
- 3 days ago - Avalo Therapeutics Transcript: 12th Annual Cantor Fitzgerald Global Healthcare Conference - Transcripts
- 8 days ago - Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 10 days ago - Avalo Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Avalo Therapeutics price target lowered to $48 from $50 at Guggenheim - TheFly
- 5 weeks ago - Avalo Therapeutics price target lowered to $30 from $35 at H.C. Wainwright - TheFly
- 5 weeks ago - Avalo Therapeutics reports Q2 EPS (83c), consensus (62c) - TheFly
- 5 weeks ago - Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates - GlobeNewsWire
- 5 weeks ago - Avalo Therapeutics Quarterly report: Q2 2026 - Filings